ProQR Therapeutics NV (PRQR)
1.625
-0.02
(-1.52%)
USD |
NASDAQ |
Oct 07, 16:00
1.625
0.00 (0.00%)
After-Hours: 16:18
ProQR Therapeutics EPS Diluted (Quarterly) : -0.0923 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0923 |
| March 31, 2026 | -0.1486 |
| December 31, 2025 | -0.1008 |
| September 30, 2025 | -0.1221 |
| June 30, 2025 | -0.131 |
| March 31, 2025 | -0.1007 |
| December 31, 2024 | -0.1028 |
| September 30, 2024 | -0.109 |
| June 30, 2024 | -0.0355 |
| March 31, 2024 | -0.1019 |
| December 31, 2023 | -0.0752 |
| September 30, 2023 | -0.0767 |
| June 30, 2023 | -0.1075 |
| March 31, 2023 | -0.1185 |
| December 31, 2022 | -0.1752 |
| September 30, 2022 | -0.329 |
| June 30, 2022 | -0.222 |
| March 31, 2022 | -0.227 |
| December 31, 2021 | -0.2923 |
| September 30, 2021 | -0.2598 |
| June 30, 2021 | -0.287 |
| March 31, 2021 | -0.2988 |
| December 31, 2020 | -0.3141 |
| September 30, 2020 | -0.3072 |
| June 30, 2020 | -0.0905 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3544 |
| December 31, 2019 | -0.4332 |
| September 30, 2019 | -0.3468 |
| June 30, 2019 | -0.3365 |
| March 31, 2019 | -0.4134 |
| December 31, 2018 | -0.3806 |
| September 30, 2018 | -0.2078 |
| June 30, 2018 | -0.2739 |
| March 31, 2018 | -0.4104 |
| December 31, 2017 | -0.4592 |
| September 30, 2017 | -0.4934 |
| June 30, 2017 | -0.5176 |
| March 31, 2017 | -0.4796 |
| December 31, 2016 | -0.4095 |
| September 30, 2016 | -0.4799 |
| June 30, 2016 | -0.4855 |
| March 31, 2016 | -0.4851 |
| December 31, 2015 | -0.2846 |
| September 30, 2015 | -0.3001 |
| June 30, 2015 | -0.4093 |
| March 31, 2015 | 0.0112 |
| December 31, 2014 | -0.1124 |
| September 30, 2014 | -0.1855 |
| June 30, 2014 | -144.64 |
| March 31, 2014 | -0.4111 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharming Group NV | 0.02 |
| NewAmsterdam Pharma Co. NV | -0.5199 |
| argenx SE | -- |
| Mirum Pharmaceuticals, Inc. | -1.061 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.15M |
| Revenue (Quarterly) | 10.18M |
| Total Expenses (Quarterly) | 20.33M |
| Enterprise Value | 114.03M |
| Gross Profit Margin (Quarterly) | 91.93% |
| Profit Margin (Quarterly) | -99.65% |
| Earnings Yield | -28.54% |
| Normalized Earnings Yield | -28.58 |